1 active not recruiting, 1 completed, 1 recruiting. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Recruiting 1 |
Follow PRU(Platelet Reactivity Unit): new trials by email Literature Review of PRU(Platelet Reactivity Unit) trials Research Report on PRU(Platelet Reactivity Unit)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease Aspirin, Clopidogrel, Ticagrelor - Peripheral Arterial Disease (PAD), Amputation | Not applicable | Recruiting | Massachusetts General Hospital | 484 | 2025-04-29 | 2026-09-11 |
| Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization Aspirin, Clopidogrel, Ticagrelor - Thrombosis, Arterial Occlusive Diseases | Not applicable | Active not recruiting | Massachusetts General Hospital | 144 | 2023-01-01 | 2026-10-13 |
| Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention) PRU(Platelet reactivity unit) - PRU(Platelet Reactivity Unit), APT(Antiplatelet Therapy) | Completed | Taipei City Hospital | 334 | 2015-01-01 | 2019-11-22 |
Peripheral Arterial Disease (2) · Thrombosis (2) · Arterial Occlusive Diseases (1)
Arteriosclerosis (2) · Atherosclerosis (2) · Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Peripheral Vascular Diseases (2) · Vascular Diseases (2) · Arterial Occlusive Diseases (1)
Aspirin (2) · Clopidogrel (2) · Thrombelastography (2) · Ticagrelor (2) · Rivaroxaban (1)
Massachusetts General Hospital (2) · Taipei City Hospital (1)
United States (2) · Taiwan (1)
Anahita Dua, MBChB, MBA, MSC (1) · Chen Yueh Chung, chief doctor (1)
R21AG077310 (1)